Researchers uncover the biology and therapy behind a uncommon autoinflammatory illness

The absence of a protein that prompts the physique’s antiviral defenses may cause a uncommon rheumatoid-like autoinflammatory situation that’s treatable with an FDA-approved class of medicine generally known as TNF (tumor necrosis issue) inhibitors, researchers have discovered.